These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Cavinton in epilepsy treatment and prevention]. Dutov AA; Gol'tvanitsa VA; Temnikova IV; Fedetova AA Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):59-61. PubMed ID: 11765618 [No Abstract] [Full Text] [Related]
49. On the way to cure epilepsy. Pitkänen A Expert Rev Neurother; 2004 Nov; 4(6):917-20. PubMed ID: 15853516 [No Abstract] [Full Text] [Related]
50. [Aetiology of epileptic seizures in a rehabilitation centre]. Carod-Artal FJ; Vargas AP; Mesquita HM Rev Neurol; 2009 Oct 1-15; 49(7):349-53. PubMed ID: 19774528 [TBL] [Abstract][Full Text] [Related]
51. Central nervous system infections and epilepsy. Singh G; Prabhakar S; Modi M Epilepsia; 2008 Aug; 49 Suppl 6():1. PubMed ID: 18754953 [No Abstract] [Full Text] [Related]
52. Neuroprotective strategies in epilepsy. Carlen PL; Pelletier MR; Ouanounou A; Tymianski M; Zhang L Adv Exp Med Biol; 2002; 497():209-24. PubMed ID: 11993734 [TBL] [Abstract][Full Text] [Related]
53. MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion. Löscher W; Delanty N Pharmacogenomics; 2009 May; 10(5):711-3. PubMed ID: 19450121 [No Abstract] [Full Text] [Related]
54. The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy. Zemlyak I; Manley N; Vulih-Shultzman I; Cutler AB; Graber K; Sapolsky RM; Gozes I J Neurochem; 2009 Dec; 111(5):1252-63. PubMed ID: 19799711 [TBL] [Abstract][Full Text] [Related]
55. Significance of the EEG in the decision to initiate antiepileptic treatment in patients with epilepsy: a perspective on recent evidence. Jaseja H Epilepsy Behav; 2009 Oct; 16(2):345-6. PubMed ID: 19699155 [TBL] [Abstract][Full Text] [Related]
56. Childhood epilepsy: secondary prevention is crucial. Deonna T Dev Med Child Neurol Suppl; 2003 Aug; 95():38-41. PubMed ID: 12898991 [No Abstract] [Full Text] [Related]
57. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? Robertson NJ; Tan S; Groenendaal F; van Bel F; Juul SE; Bennet L; Derrick M; Back SA; Valdez RC; Northington F; Gunn AJ; Mallard C J Pediatr; 2012 Apr; 160(4):544-552.e4. PubMed ID: 22325255 [No Abstract] [Full Text] [Related]
58. Children grow-up.. Striano P; Striano S Epileptic Disord; 2008 Mar; 10(1):71-2. PubMed ID: 18494088 [No Abstract] [Full Text] [Related]
59. Is the epilepsy responsive or resistant? Only time will tell. French JA Ann Neurol; 2009 May; 65(5):489-90. PubMed ID: 19479723 [No Abstract] [Full Text] [Related]